Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries (OP: NYMXF ) 0.1100 -0.0300 (-21.43%) Streaming Delayed Price Updated: 9:30 AM EDT, Sep 10, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 2,266 Open 0.1400 Bid (Size) N/A (0) Ask (Size) N/A (0) Prev. Close 0.1400 Today's Range 0.1100 - 0.1100 52wk Range 0.0001 - 1.400 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Nymox Announces Filing of Annual Report August 30, 2024 From Nymox Pharmaceutical Corporation Via GlobeNewswire Nymox Annual Report July 18, 2024 From Nymox Pharmaceutical Corporation Via GlobeNewswire Performance YTD -78.07% -78.07% 1 Month +36566.67% +36566.67% 3 Month -47.62% -47.62% 6 Month -68.95% -68.95% 1 Year -71.05% -71.05% More News Read More Nymox Required to Resubmit Application to DKMA July 16, 2024 From Nymox Pharmaceutical Corporation Via GlobeNewswire Nymox Reports Victory in Bahamas Litigation Against Terminated Ex-Employees – Court Awards Costs and Damages March 27, 2024 From Nymox Pharmaceutical Corporation Via GlobeNewswire Nymox December 27 Message to Shareholders December 27, 2023 From Nymox Pharmaceutical Corporation Via GlobeNewswire Nymox Reports California Court Issues Preliminary Injunction Against Defendants Lanham, Riley, Cutler and Others November 30, 2023 From Nymox Pharmaceutical Corporation Via GlobeNewswire $250 Million Lawsuit Filed Against AscellaHealth by Nymox Accepted and Summons Issued in California Court November 21, 2023 From Nymox Pharmaceutical Corporation Via GlobeNewswire Nymox Pharmaceutical Corporation Sues AscellaHealth For $250 Million November 09, 2023 From Nymox Pharmaceutical Corporation Via GlobeNewswire NYMOX REPORTS: Bahamian Court Today Suspends Order of October 3, 2023 Rendering Riley-Lanham and Accomplices Planned Vote Unauthorized November 03, 2023 From Nymox Pharmaceutical Corporation Via GlobeNewswire NYMOX REPORTS NOTICE: California Court Issued A Temporary Restraining Order Enjoining Lanham, Riley, Cutler And Their Nevada Company After Court Hearing In Santa Ana, California, November 2, 2023 November 03, 2023 From Nymox Pharmaceutical Corporation Via GlobeNewswire IMPORTANT MESSAGE TO NYMOX SHAREHOLDERS: NYMOX Cautions Against Unauthorized Improper Shareholder Meeting and Unauthorized Unregistered Solicitations November 02, 2023 From Nymox Pharmaceutical Corporation Via GlobeNewswire IMPORTANT NOTICE: NYMOX Cautions Shareholders Not to Take Calls or Participate in Unauthorized Improper Shareholder Meeting October 31, 2023 From Nymox Pharmaceutical Corporation Via GlobeNewswire Notice: Nymox Informs Its Shareholders Not to Take Calls or Participate in An Unauthorized and Improper Shareholder Meeting October 27, 2023 From Nymox Pharmaceutical Corporation Via GlobeNewswire Nymox Reports New NYMOZARFEX Marketing Application is Accepted For Review October 26, 2023 From Nymox Pharmaceutical Corporation Via GlobeNewswire Nymox Announces Submission of New Marketing Authorization Application Submission for NYMOZARFEX (TM) for BPH September 25, 2023 From Nymox Pharmaceutical Corporation Via GlobeNewswire Nymox Reports Completion of $2 Million Private Placement August 29, 2023 From Nymox Pharmaceutical Corporation Via GlobeNewswire Nymox Announces $2 Million Private Placement August 02, 2023 From Nymox Pharmaceutical Corporation Via GlobeNewswire Nymox's 3-month ex-CFO was Awarded an Unauthorized and Undisclosed Treasury Directive for 100,000 Shares of Nymox Stock Without the Knowledge or Approval of the Nymox Board or Nymox’s CEO July 31, 2023 From Nymox Pharmaceutical Corporation Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.